← Pharmacy curriculum
Module 055 submodulesIntegrated therapeutics

Gastrointestinal, Immunology, and CNS I

Move from gastrointestinal disease into immune regulation and foundational psychiatric therapeutics.

01

Distinguish acid, motility, and inflammatory GI disorders.

02

Recognize immune suppression and monitoring priorities.

03

Compare foundational psychiatric drug classes.

04

Integrate efficacy, safety, adherence, and patient experience.

05.01

GERD, Peptic Ulcer Disease, and Upper GI Care

Upper gastrointestinal treatment depends on symptom pattern, alarm features, acid exposure, ulcer cause, medication injury, and adherence to administration instructions.

What to learn
  • GERD assessment and alarm symptoms
  • Antacids, H2 blockers, and proton pump inhibitors
  • Peptic ulcer disease and Helicobacter pylori
  • NSAID-related injury and deprescribing
05.02

Bowel and Inflammatory GI Disorders

Constipation, diarrhea, IBS, and inflammatory bowel disease can look similar while requiring different assessments and therapeutic goals.

What to learn
  • Constipation and diarrhea evaluation
  • Irritable bowel syndrome
  • Inflammatory bowel disease
  • Hydration, electrolytes, and medication causes
05.03

Immune, Inflammatory, and Transplant Pharmacology

Immune therapies alter signaling, cell activation, cytokines, or proliferation and require balancing disease control against infection, malignancy, and organ toxicity.

What to learn
  • Innate and adaptive immunity
  • Corticosteroids and conventional immunomodulators
  • Biologic and targeted therapies
  • Transplant immunosuppression and monitoring
05.04

Depression, Anxiety, and Sleep

Psychiatric treatment requires symptom, function, safety, time course, adherence, comorbidity, and patient preference to be considered together.

What to learn
  • Depressive and anxiety disorders
  • Antidepressant classes and onset
  • Benzodiazepines and other anxiolytics
  • Insomnia, activation, withdrawal, and suicidality monitoring
05.05

Psychosis and Bipolar Disorder

Antipsychotic and mood-stabilizing therapy balances acute symptom control, relapse prevention, metabolic and neurologic toxicity, and adherence.

What to learn
  • Positive, negative, and cognitive symptoms
  • Antipsychotic mechanisms and adverse effects
  • Bipolar mood states and maintenance
  • Movement, metabolic, cardiac, and blood monitoring

Check the connections.

Answer one question from each submodule. Submit the full set to reveal the reasoning.

0 of 5 answered
01Which finding is an alarm feature that warrants further evaluation rather than routine self-treatment of reflux?
02Which symptom should prompt evaluation rather than uncomplicated self-care for diarrhea?
03Why is infection screening important before many biologic immune therapies?
04What is an important counseling point when beginning many antidepressants?
05Which monitoring domain is important for many second-generation antipsychotics?
Answer every question to submit.
PharmacyOpen tools